Cargando…

Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications

Janus particles have emerged as a novel and smart material that could improve pharmaceutical formulation, drug delivery, and theranostics. Janus particles have two distinct compartments that differ in functionality, physicochemical properties, and morphological characteristics, among other conventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Kei Xian, Danquah, Michael K., Jeevanandam, Jaison, Barhoum, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967574/
https://www.ncbi.nlm.nih.gov/pubmed/36839746
http://dx.doi.org/10.3390/pharmaceutics15020423
_version_ 1784897298678939648
author Tan, Kei Xian
Danquah, Michael K.
Jeevanandam, Jaison
Barhoum, Ahmed
author_facet Tan, Kei Xian
Danquah, Michael K.
Jeevanandam, Jaison
Barhoum, Ahmed
author_sort Tan, Kei Xian
collection PubMed
description Janus particles have emerged as a novel and smart material that could improve pharmaceutical formulation, drug delivery, and theranostics. Janus particles have two distinct compartments that differ in functionality, physicochemical properties, and morphological characteristics, among other conventional particles. Recently, Janus particles have attracted considerable attention as effective particulate drug delivery systems as they can accommodate two opposing pharmaceutical agents that can be engineered at the molecular level to achieve better target affinity, lower drug dosage to achieve a therapeutic effect, and controlled drug release with improved pharmacokinetics and pharmacodynamics. This article discusses the development of Janus particles for tailored and improved delivery of pharmaceutical agents for diabetes treatment and antimicrobial applications. It provides an account of advances in the synthesis of Janus particles from various materials using different approaches. It appraises Janus particles as a promising particulate system with the potential to improve conventional delivery systems, providing a better loading capacity and targeting specificity whilst promoting multi-drugs loading and single-dose-drug administration.
format Online
Article
Text
id pubmed-9967574
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99675742023-02-27 Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications Tan, Kei Xian Danquah, Michael K. Jeevanandam, Jaison Barhoum, Ahmed Pharmaceutics Review Janus particles have emerged as a novel and smart material that could improve pharmaceutical formulation, drug delivery, and theranostics. Janus particles have two distinct compartments that differ in functionality, physicochemical properties, and morphological characteristics, among other conventional particles. Recently, Janus particles have attracted considerable attention as effective particulate drug delivery systems as they can accommodate two opposing pharmaceutical agents that can be engineered at the molecular level to achieve better target affinity, lower drug dosage to achieve a therapeutic effect, and controlled drug release with improved pharmacokinetics and pharmacodynamics. This article discusses the development of Janus particles for tailored and improved delivery of pharmaceutical agents for diabetes treatment and antimicrobial applications. It provides an account of advances in the synthesis of Janus particles from various materials using different approaches. It appraises Janus particles as a promising particulate system with the potential to improve conventional delivery systems, providing a better loading capacity and targeting specificity whilst promoting multi-drugs loading and single-dose-drug administration. MDPI 2023-01-27 /pmc/articles/PMC9967574/ /pubmed/36839746 http://dx.doi.org/10.3390/pharmaceutics15020423 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tan, Kei Xian
Danquah, Michael K.
Jeevanandam, Jaison
Barhoum, Ahmed
Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications
title Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications
title_full Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications
title_fullStr Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications
title_full_unstemmed Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications
title_short Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications
title_sort development of janus particles as potential drug delivery systems for diabetes treatment and antimicrobial applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967574/
https://www.ncbi.nlm.nih.gov/pubmed/36839746
http://dx.doi.org/10.3390/pharmaceutics15020423
work_keys_str_mv AT tankeixian developmentofjanusparticlesaspotentialdrugdeliverysystemsfordiabetestreatmentandantimicrobialapplications
AT danquahmichaelk developmentofjanusparticlesaspotentialdrugdeliverysystemsfordiabetestreatmentandantimicrobialapplications
AT jeevanandamjaison developmentofjanusparticlesaspotentialdrugdeliverysystemsfordiabetestreatmentandantimicrobialapplications
AT barhoumahmed developmentofjanusparticlesaspotentialdrugdeliverysystemsfordiabetestreatmentandantimicrobialapplications